vs
Healthpeak Properties（DOC）与INTERPARFUMS INC（IPAR）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是INTERPARFUMS INC的1.9倍（$719.4M vs $386.2M），Healthpeak Properties净利率更高（73.2% vs 7.3%，领先65.9%），INTERPARFUMS INC同比增速更快（6.8% vs 3.1%），Healthpeak Properties自由现金流更多（$357.0M vs $145.0M），过去两年INTERPARFUMS INC的营收复合增速更高（9.2% vs 8.9%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
Inter Parfums Inc是全球知名的高端香水企业，开发、生产并销售多款授权香水、身体护理及相关美妆产品，与多家顶级奢侈时尚生活方式品牌合作推出联名香氛系列，产品覆盖全球主要市场，通过百货、美妆专营店及官方电商渠道触达消费者。
DOC vs IPAR — 直观对比
营收规模更大
DOC
是对方的1.9倍
$386.2M
营收增速更快
IPAR
高出3.8%
3.1%
净利率更高
DOC
高出65.9%
7.3%
自由现金流更多
DOC
多$212.0M
$145.0M
两年增速更快
IPAR
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $386.2M |
| 净利润 | $114.0M | $28.1M |
| 毛利率 | — | 61.5% |
| 营业利润率 | 17.4% | 7.1% |
| 净利率 | 73.2% | 7.3% |
| 营收同比 | 3.1% | 6.8% |
| 净利润同比 | 2406.4% | 16.0% |
| 每股收益（稀释后） | $0.16 | $0.88 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCIPAR
| Q4 25 | $719.4M | $386.2M | ||
| Q3 25 | $705.9M | $429.6M | ||
| Q2 25 | $694.3M | $333.9M | ||
| Q1 25 | $702.9M | $338.8M | ||
| Q4 24 | $698.0M | $361.5M | ||
| Q3 24 | $700.4M | $424.6M | ||
| Q2 24 | $695.5M | $342.2M | ||
| Q1 24 | $606.6M | $324.0M |
净利润DOCIPAR
| Q4 25 | $114.0M | $28.1M | ||
| Q3 25 | $-117.1M | $65.8M | ||
| Q2 25 | $31.7M | $32.0M | ||
| Q1 25 | $42.8M | $42.5M | ||
| Q4 24 | $4.5M | $24.2M | ||
| Q3 24 | $85.9M | $62.3M | ||
| Q2 24 | $146.0M | $36.8M | ||
| Q1 24 | $6.7M | $41.0M |
毛利率DOCIPAR
| Q4 25 | — | 61.5% | ||
| Q3 25 | 58.6% | 63.5% | ||
| Q2 25 | 60.2% | 66.2% | ||
| Q1 25 | 61.1% | 63.7% | ||
| Q4 24 | 60.3% | 64.5% | ||
| Q3 24 | 60.0% | 63.9% | ||
| Q2 24 | 60.6% | 64.5% | ||
| Q1 24 | 59.8% | 62.5% |
营业利润率DOCIPAR
| Q4 25 | 17.4% | 7.1% | ||
| Q3 25 | 9.2% | 25.3% | ||
| Q2 25 | 5.7% | 17.7% | ||
| Q1 25 | 7.7% | 22.2% | ||
| Q4 24 | -2.2% | 10.0% | ||
| Q3 24 | 14.1% | 25.0% | ||
| Q2 24 | 22.3% | 18.9% | ||
| Q1 24 | 3.7% | 21.0% |
净利率DOCIPAR
| Q4 25 | 73.2% | 7.3% | ||
| Q3 25 | -16.6% | 15.3% | ||
| Q2 25 | 4.6% | 9.6% | ||
| Q1 25 | 6.1% | 12.5% | ||
| Q4 24 | 0.7% | 6.7% | ||
| Q3 24 | 12.3% | 14.7% | ||
| Q2 24 | 21.0% | 10.8% | ||
| Q1 24 | 1.1% | 12.7% |
每股收益（稀释后）DOCIPAR
| Q4 25 | $0.16 | $0.88 | ||
| Q3 25 | $-0.17 | $2.05 | ||
| Q2 25 | $0.05 | $0.99 | ||
| Q1 25 | $0.06 | $1.32 | ||
| Q4 24 | $0.02 | $0.78 | ||
| Q3 24 | $0.12 | $1.93 | ||
| Q2 24 | $0.21 | $1.14 | ||
| Q1 24 | $0.01 | $1.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $137.1M |
| 总债务越低越好 | $9.8B | $176.0M |
| 股东权益账面价值 | $7.5B | $880.7M |
| 总资产 | $20.3B | $1.6B |
| 负债/权益比越低杠杆越低 | 1.31× | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资DOCIPAR
| Q4 25 | $467.5M | $137.1M | ||
| Q3 25 | $91.0M | $77.5M | ||
| Q2 25 | $89.4M | $53.9M | ||
| Q1 25 | $70.6M | $75.3M | ||
| Q4 24 | $119.8M | $109.3M | ||
| Q3 24 | $180.4M | $78.8M | ||
| Q2 24 | $106.9M | $37.7M | ||
| Q1 24 | $101.8M | $76.1M |
总债务DOCIPAR
| Q4 25 | $9.8B | $176.0M | ||
| Q3 25 | $9.1B | — | ||
| Q2 25 | $9.0B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.7B | $157.3M | ||
| Q3 24 | $8.6B | — | ||
| Q2 24 | $8.6B | — | ||
| Q1 24 | $8.8B | — |
股东权益DOCIPAR
| Q4 25 | $7.5B | $880.7M | ||
| Q3 25 | $7.6B | $870.9M | ||
| Q2 25 | $7.9B | $839.4M | ||
| Q1 25 | $8.2B | $788.6M | ||
| Q4 24 | $8.4B | $744.9M | ||
| Q3 24 | $8.6B | $778.5M | ||
| Q2 24 | $8.8B | $717.1M | ||
| Q1 24 | $8.9B | $708.1M |
总资产DOCIPAR
| Q4 25 | $20.3B | $1.6B | ||
| Q3 25 | $19.6B | $1.6B | ||
| Q2 25 | $19.8B | $1.6B | ||
| Q1 25 | $19.8B | $1.4B | ||
| Q4 24 | $19.9B | $1.4B | ||
| Q3 24 | $20.0B | $1.5B | ||
| Q2 24 | $20.2B | $1.4B | ||
| Q1 24 | $20.5B | $1.3B |
负债/权益比DOCIPAR
| Q4 25 | 1.31× | 0.20× | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.14× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 1.04× | 0.21× | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.98× | — | ||
| Q1 24 | 0.99× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $146.5M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $145.0M |
| 自由现金流率自由现金流/营收 | 49.6% | 37.5% |
| 资本支出强度资本支出/营收 | 124.4% | 0.4% |
| 现金转化率经营现金流/净利润 | 10.99× | 5.21× |
| 过去12个月自由现金流最近4个季度 | — | $190.5M |
8季度趋势，按日历期对齐
经营现金流DOCIPAR
| Q4 25 | $1.3B | $146.5M | ||
| Q3 25 | $315.0M | $63.9M | ||
| Q2 25 | $363.5M | $11.9M | ||
| Q1 25 | $279.4M | $-7.4M | ||
| Q4 24 | $1.1B | $138.0M | ||
| Q3 24 | $318.2M | $76.1M | ||
| Q2 24 | $316.2M | $25.5M | ||
| Q1 24 | $152.6M | $-52.0M |
自由现金流DOCIPAR
| Q4 25 | $357.0M | $145.0M | ||
| Q3 25 | — | $57.6M | ||
| Q2 25 | — | $-3.3M | ||
| Q1 25 | — | $-8.8M | ||
| Q4 24 | $333.7M | $136.1M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $24.4M | ||
| Q1 24 | — | $-53.0M |
自由现金流率DOCIPAR
| Q4 25 | 49.6% | 37.5% | ||
| Q3 25 | — | 13.4% | ||
| Q2 25 | — | -1.0% | ||
| Q1 25 | — | -2.6% | ||
| Q4 24 | 47.8% | 37.7% | ||
| Q3 24 | — | 17.8% | ||
| Q2 24 | — | 7.1% | ||
| Q1 24 | — | -16.4% |
资本支出强度DOCIPAR
| Q4 25 | 124.4% | 0.4% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 4.5% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | 105.6% | 0.5% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.3% |
现金转化率DOCIPAR
| Q4 25 | 10.99× | 5.21× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | 11.48× | 0.37× | ||
| Q1 25 | 6.52× | -0.17× | ||
| Q4 24 | 235.43× | 5.69× | ||
| Q3 24 | 3.71× | 1.22× | ||
| Q2 24 | 2.17× | 0.69× | ||
| Q1 24 | 22.85× | -1.27× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
IPAR
| European Based Operations | $232.7M | 60% |
| United States Based Operations | $155.2M | 40% |
